PDT Partners’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-41,166
Closed -$1.2M 721
2024
Q1
$1.2M Sell
41,166
-8,712
-17% -$264K 0.11% 295
2023
Q4
$1.88M Buy
49,878
+31,706
+174% +$1.17M 0.21% 157
2023
Q3
$818K Buy
+18,172
New +$1.1M 0.1% 330
2023
Q2
Sell
-4,800
Closed -$282K 634
2023
Q1
$282K Buy
+4,800
New +$265K 0.04% 472
2015
Q4
Sell
-14,410
Closed -$448K 788
2015
Q3
$448K Buy
14,410
+5,221
+57% +$187K 0.01% 933
2015
Q2
$347K Sell
9,189
-5,621
-38% -$205K 0.01% 1092
2015
Q1
$520K Buy
+14,810
New +$488K 0.01% 1000

Other funds holding OMCL

PDT Partners's OMCL Position: Q2 2024 in Review

PDT Partners sold out of Omnicell (OMCL) in Q2 2024, closing a stake of 41,166 shares — an estimated $1.2M sold.

PDT Partners first reported a position in OMCL in Q1 2015 and held it in 7 quarters. The position peaked at $1.88M in Q4 2023. 240 funds tracked by Wall St. Rank hold OMCL as of Q2 2024.

  • PDT Partners reported no remaining Omnicell position as of Q2 2024 after selling out during the quarter.
  • PDT Partners sold 41,166 Omnicell shares in Q2 2024, an estimated $1.2M.
  • PDT Partners first reported a position in Omnicell in Q1 2015 and held it in 7 quarters.
  • PDT Partners's Omnicell position peaked at $1.88M in Q4 2023.
  • 240 funds tracked by Wall St. Rank held Omnicell as of Q2 2024.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.